Effect sizes in ongoing randomized controlled critical care trials

Critical Care

Volumn 21, Issue 1, 2017, Pages

  Ridgeon, Elliott E ^a   Bellomo, Rinaldo ^b,c   Aberegg, Scott K ^d   Sweeney, Rob Mac ^e   Varughese, Rachel S ^a   Landoni, Giovanni ^f,g   Young, Paul J ^h  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b MONASH UNIVERSITY   (Australia)

^c AUSTIN HOSPITAL   (Australia)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e ROYAL VICTORIA HOSPITAL   (United Kingdom)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h WELLINGTON HOSPITAL   (New Zealand)

Author keywords

Clinical trial design; Critical care; Intensive care; Intensive care unit; Randomized clinical trial

Indexed keywords

HYDROCORTISONE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; PANTOPRAZOLE; TICAGRELOR; TRANEXAMIC ACID;

ABSOLUTE MORTALITY; ACCURACY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; COMMUNITY ACQUIRED PNEUMONIA; CRITICALLY ILL PATIENT; DEMOGRAPHY; EFFECT SIZE; FACTUAL DATABASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LANDMARK MORTALITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; RISK REDUCTION; SAMPLE SIZE; SEPTIC SHOCK; STRESS ULCER; STUDY DESIGN; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; CRITICAL CARE OUTCOME; HOSPITAL MORTALITY; METHODOLOGY; NONPARAMETRIC TEST; PATIENT SELECTION; PROCEDURES; QUESTIONNAIRE; REGISTER; STANDARDS; STATISTICS AND NUMERICAL DATA;

CRITICAL CARE OUTCOMES; HOSPITAL MORTALITY; HUMANS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RESEARCH DESIGN; STATISTICS, NONPARAMETRIC; SURVEYS AND QUESTIONNAIRES;

EID: 85020192891     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-017-1726-x     Document Type: Article

References (31)

1. Taori G, Ho KM, George C, Bellomo R, Webb SA, Hart GK, et al. Landmark survival as an end-point for trials in critically ill patients - comparison of alternative durations of follow-up: an exploratory analysis. Crit Care. 2009;13:R128.
2. Gattinoni L, Tonetti T, Quintel M. Improved survival in critically ill patients: are large RCTs more useful than personalized medicine? We are not sure. Intensive Care Med. 2016;42:1781-3.
3. Bellomo R, Landoni G, Young P. Improved survival in critically ill patients: are large RCTs more useful than personalized medicine? Yes. Intensive Care Med. 2016;42:1775-7.
4. Vincent JL. Improved survival in critically ill patients: are large RCTs more useful than personalized medicine? No. Intensive Care Med. 2016;42:1778-80.
5. Aberegg SK, Richards DR, O'Brien JM. Delta inflation: a bias in the design of randomized controlled trials in critical care medicine. Crit Care. 2010;14:R77.
6. Aberegg S. Challenging orthodoxy in critical care trial design: physiological responsiveness. Ann Transl Med. 2016;4:147.
7. Kalil AC, Sun J. Bayesian methodology for the design and interpretation of clinical trials in critical care medicine: a primer for clinicians. Crit Care Med. 2014;42:2267-77.
8. Venkatesh B, Myburgh J, Finfer S, Webb SA, Cohen J, Bellomo R, et al. The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock. Crit Care Resusc. 2013;15:83-8.
9. Critical Care Reviews. http://www.criticalcarereviews.com/.
10. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434-42.
11. Roberts I, Coats T, Edwards P, Gilmore I, Jairath V, Ker K, et al. HALT-IT - tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. Trials. 2014;15:450.
12. Dewan Y, Komolafe EO, Mejia-Mantilla JH, Perel P, Roberts I, Shakur H. CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials. 2012;13:87.
13. Krag M, Perner A, Wetterslev J, Wise MP, Borthwick M, Bendel S, et al. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial. Trials. 2016;17:205.
14. Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43. https://www.clinicaltrials.gov/ct2/show/NCT01563263. Accessed 15 Sept 2015.
15. Early Spontaneous Breathing in Acute Respiratory Distress Syndrome (BiRDS). https://clinicaltrials.gov/ct2/show/NCT01862016. Accessed 15 Sept 2015.
16. Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Mechanical Ventilation (NONSEDA). https://clinicaltrials.gov/ct2/show/NCT01967680. Accessed 15 Sept 2015.
17. The Augmented Versus Routine Approach to Giving Energy Trial (TARGET). https://clinicaltrials.gov/ct2/show/NCT02306746. Accessed 15 Sept 2015.
18. Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients (SuDDICU-ANZ). https://clinicaltrials.gov/ct2/show/NCT02389036. Accessed 15 Sept 2015.
19. Ticagrelor in Severe Community Acquired Pneumonia (TCAP). https://clinicaltrials.gov/ct2/show/NCT01998399. Accessed 15 Sept 2015.
20. Ospina-Tascon GA, Buchele GL, Vincent JL. Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med. 2008;36:1311-22.
21. Harhay MO, Wagner J, Ratcliffe SJ, Bronheim RS, Gopal A, Green S, et al. Outcomes and statistical power in adult critical care randomized trials. Am J Respir Crit Care Med. 2014;189:1469-78.
22. Ridgeon EE, Young PJ, Bellomo R, Mucchetti M, Lembo R, Landoni G. The fragility index in multicenter randomized controlled critical care trials. Crit Care Med. 2016;44:1278-84.
23. Moatti M, Zohar S, Facon T, Moreau P, Mary JY, Chevret S. Modeling of experts' divergent prior beliefs for a sequential phase III clinical trial. Clin Trials. 2013;10:505-14.
24. Pibouleau L, Chevret S. An internet-based method to elicit experts' beliefs for Bayesian priors: a case study in intracranial stent evaluation. Int J Technol Assess Health Care. 2014;30:446-53.
25. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317:141-5.
26. Held L. A nomogram for P values. BMC Med Res Methodol. 2010;10:21.
27. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124.
28. Goodwin AJ. Critical care clinical trials: getting off the roller coaster. Chest. 2012;142:563-7.
29. Nagendran M, Pereira TV, Kiew G, Altman DG, Maruthappu M, Ioannidis JP, et al. Very large treatment effects in randomised trials as an empirical marker to indicate whether subsequent trials are necessary: meta-epidemiological assessment. BMJ. 2016;355:i5432.
30. Young PJ, Delaney AP, Dulhunty JM, Venkatesh B. Critical care statistical analysis plans: in reply. Crit Care Resusc. 2014;16:76-7.
31. Mann A. The power of prediction markets. Nature. 2016;538:308-10.